TriWise Capital
VC Fund
Shenzhen, China
TriWise Capital is an investment firm that focuses on venture capital and M&A business.
- Total investments:
- 28
- Last investment:
- Lead investor:
- 36%
Last updated:
For AI agents: llms.txt
Industries TriWise Capital invests in
Stages TriWise Capital invests in
Countries TriWise Capital invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Dajie Tang
|
|||
4 more contacts available
Investment Focus
Industry
- Health Care 13 (46%)
- Biotechnology 12 (43%)
- Medical 10 (36%)
- Pharmaceutical 9 (32%)
- Biopharma 7 (25%)
Stage
- Series A 6 (21%)
- Series B 6 (21%)
- Seed 5 (18%)
- Series C 5 (18%)
- Angel 3 (11%)
Country
- China 21 (75%)
- United States 1 (4%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Dajie Tang
Founding Partner
|
Founding Partner | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Bite Micro
|
Better Micro Medical is a medical device company that is characterized by intervention and non-implantation, and offers doctors with comprehensive solutions in the field of peripheral vascular and structural heart disease. | $14.5M / Series B / Mar 16, 2026 | |
Chongqing Hanpei Biotechnology
|
Chongqing Hanpei Biotechnology focuses on the development of innovative and generic drugs for pets. | $1.4M / Seed / Dec 02, 2025 | |
Punuokang Biotechnology
|
Punuokang Bio is a veterinary pharmaceutical developer focusing on innovative treatments for pet metabolic diseases like heart disease, tumors, and kidney disease, which aligns with wider industry trends of advancing pet medicines for chronic conditions in companion animals. | $1.4M / Angel / Jul 29, 2025 | |
Novlead Biotech
|
Novlead Biotech contributes to a safer and healthier human well-being through our technological innovations. | Series C / Apr 15, 2025 | |
|
Mitouke Biopharma
|
Mitouke Biopharma is a manufacturer and supplier specializing in probiotics, enzymes, nutraceuticals, and feed supplements. The company produces high-quality products such as pre-probiotics, pharmaceutical enzymes, and nutraceutical supplements that are used across industries including pharmaceuticals, food, detergents, textiles, and veterinaryformulations. | Seed / Apr 07, 2025 | |
|
Yaoyi Life
|
Yaoyi Life Sciences develops animal health drugs, including vaccine adjuvants and antibacterial materials. | Angel / Feb 10, 2025 | |
Crystal Egg Bio
|
Crystal Egg is a biopharmaceutical company dedicated to the independent research and development of first in class innovative new drugs for major diseases such as depression, chronic kidney disease, pain and rare diseases, as well as providing customers with high-quality products and R&D services in membrane protein-related fields. enterprise.The company has built membrane protein expression and purification platforms, structural biology platforms, pharmacology platforms and nanobody screening platforms, and has rich R&D pipelines in the fields of ion channels and GPCRs. | $1.4M / Series A / Sep 13, 2024 | |
BiyoPharma
|
BiyoPharma focuses on the research and development of innovative drugs for neurological diseases, including episodic and chronic migraines, through international technology platforms and improved treatment options. | Seed / Apr 26, 2024 | |
Baikuirui
|
Baikuirui is an antibiotic resistance biosynthesis developer. | $1.4M / Series A / Apr 23, 2024 | |
Shentuo Biotechnology
|
Shentuo Biotechnology is a platform for gene therapy and revolutionary delivery technology that focuses on novel gene therapy medication developments. | Angel / Dec 29, 2023 | |
| See all 28 investments → | |||
Co-Investors
Matrix Partners China
3 deals together
Shenzhen Capital Group
3 deals together
China Highrun Capital Limited
2 deals together
CICC
2 deals together
Guangdong Technology Financial Group
2 deals together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does TriWise Capital invest in?
TriWise Capital invests primarily in Health Care, Biotechnology and Medical startups, most often at Series A and Series B stage. Most of the 28 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact TriWise Capital?
Public channels for TriWise Capital include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at TriWise Capital?
The team at TriWise Capital includes Dajie Tang (Founding Partner). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
